Beneficial ownership — 13D / 13G
85,017 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| American Ventures LLC, Series XII SHOT | BNKK Bonk, Inc. | 13G/A | 0% | Feb 19, 2026 | 5d |
| Kapitalo Investimentos Ltda | AUGO Aura Minerals Inc. | 13G/A | 4.9% | Dec 31, 2025 | 5d |
| FOUAD AHMED | RBNE Robin Energy Ltd. | 13G/A | 0% | Nov 6, 2026 | 8d |
| The Column Group III GP, LP | SRZN Surrozen, Inc. | 13D/A | 16.6% | Nov 6, 2026 | 8d |
| BAKER BROS. ADVISORS LP | MDGL Madrigal Pharmaceuticals, Inc. | 13D/A | 9.99% | Nov 6, 2026 | 8d |
| Mangrove Coast Investment Limited | XYF X Financial | 13D | 42.74% | Nov 6, 2026 | 8d |
| Elliott Investment Management L.P. | TFPM Triple Flag Precious Metals Corp. | 13D/A | 64.8% | Nov 6, 2026 | 8d |
| Frisco Holding II | HCA HCA Healthcare, Inc. | 13D/A | 18.6% | Nov 6, 2026 | 8d |
| Resolute Compo Holdings LLC | GPGI GPGI, Inc. | 13D/A | 17% | Nov 5, 2026 | 8d |
| ICAHN CARL C | CVI Cvr Energy Inc | 13D/A | 64.1% | Nov 5, 2026 | 8d |
| Resolute ManCo Holdings LLC | RHLD Resolute Holdings Management, Inc. | 13D/A | 52.5% | Nov 5, 2026 | 8d |
| Anthony Pompliano | SVIA Silvia, Inc. | 13D/A | 20% | Nov 5, 2026 | 8d |
| Corvus Capital Ltd. | CDT CDT Equity Inc. | 13D/A | 16.8% | Nov 5, 2026 | 8d |
| Salem Investment Partners V, Limited Partnership ( ) | GUER Guerrilla RF, Inc. | 13D/A | 9.3% | Nov 4, 2026 | 8d |
| RA CAPITAL MANAGEMENT, L.P. | SLDB Solid Biosciences Inc. | 13D/A | 10.8% | Nov 4, 2026 | 8d |
| GIC Private Ltd | MDLN Medline Inc. | 13G/A | 8.49% | Nov 4, 2026 | 8d |
| AMB Investments LLC | GUER Guerrilla RF, Inc. | 13D/A | 18.7% | Nov 4, 2026 | 8d |
| Robert Nelsen | VIR Vir Biotechnology, Inc. | 13D/A | 6.9% | Nov 4, 2026 | 8d |
| Saba Capital Management, L.P. | ZTR Virtus Total Return Fund Inc. | 13D/A | 4.92% | Nov 4, 2026 | 8d |
| Saba Capital Management, L.P. | ECF Ellsworth Growth & Income Fund Ltd | 13D/A | 13.48% | Nov 4, 2026 | 8d |
| Patriot Financial Partners III, L.P. | MCB Metropolitan Bank Holding Corp. | 13D/A | 4.76% | Nov 4, 2026 | 8d |
| HGGC Fund IV GP, Ltd. | UPLD Upland Software, Inc. | 13D/A | 21.76% | Nov 4, 2026 | 8d |
| Andrew D. Wingate, Lucinda Falk and Zena Tamler, not individually, but solely as co-trustees of DJPS P.G. Trust. | H Hyatt Hotels Corp | 13D/A | 0.4% | Nov 4, 2026 | 8d |
| OPKO HEALTH, INC. | COCP Cocrystal Pharma, Inc. | 13D/A | 29.6% | Nov 4, 2026 | 8d |
| Common Property Trust | NRC Nrc Health | 13D/A | 40.6% | Nov 4, 2026 | 8d |
| Johnson & Johnson Innovation - JJDC, Inc. | CTNM Contineum Therapeutics, Inc. | 13G/A | 5.6% | Nov 3, 2026 | 8d |
| AMTD Group Inc. | HKD AMTD Digital Inc. | 13D/A | 62.3% | Nov 2, 2026 | 8d |
| AMTD Group Inc. | TGE Generation Essentials Group | 13D | 95.7% | Nov 2, 2026 | 8d |
| MORGAN STANLEY | DIN Dine Brands Global, Inc. | 13G/A | 0.5% | Oct 31, 2026 | 8d |
| Orbis Investment Management Limited | FSV FirstService Corp | 13G/A | 7.7% | Oct 31, 2026 | 8d |
| First Trust Portfolios L.P. | CAAA First Trust Exchange-Traded Fund IV | 13G | 60.09% | Oct 31, 2026 | 8d |
| First Trust Portfolios L.P. | CAAA First Trust Exchange-Traded Fund IV | 13G/A | 10.18% | Oct 31, 2026 | 8d |
| First Trust Portfolios L.P. | CAAA First Trust Exchange-Traded Fund IV | 13G | 58.34% | Oct 31, 2026 | 8d |
| First Trust Portfolios L.P. | CAAA First Trust Exchange-Traded Fund IV | 13G | 84.12% | Oct 31, 2026 | 8d |
| MORGAN STANLEY | WIW Western Asset Inflation-Linked Opportunities & Income Fund | 13G/A | 10.1% | Oct 31, 2026 | 8d |
| Harraden Circle Investments, LLC | TVA Texas Ventures Acquisition III Corp | 13G | 12.99% | Oct 31, 2026 | 8d |
| MORGAN STANLEY | MDA MDA Space Ltd. | 13G/A | 0.3% | Oct 31, 2026 | 8d |
| T. Rowe Price Investment Management, Inc. | XENE Xenon Pharmaceuticals Inc. | 13G/A | 10.3% | Oct 31, 2026 | 8d |
| First Trust Portfolios L.P. | CAAA First Trust Exchange-Traded Fund IV | 13G | 60.81% | Oct 31, 2026 | 8d |
| ARK Investment Management LLC | TEM Tempus AI, Inc. | 13G/A | 4.91% | Oct 31, 2026 | 8d |
| First Trust Portfolios L.P. | CAAA First Trust Exchange-Traded Fund IV | 13G | 85.13% | Oct 31, 2026 | 8d |
| T. Rowe Price Investment Management, Inc. | PCVX Vaxcyte, Inc. | 13G/A | 11.6% | Oct 31, 2026 | 8d |
| METEORA CAPITAL, LLC | DYNC Dynamix Corp | 13G/A | 9.15% | Oct 31, 2026 | 8d |
| Alger Associates, Inc. 13-3017981 | ALAI Alger ETF Trust | 13G | 24.9% | Oct 31, 2026 | 8d |
| First Trust Portfolios L.P. | ACYN First Trust Exchange-Traded Fund | 13G | 16.05% | Oct 31, 2026 | 8d |
| First Trust Portfolios L.P. | AFGR First Trust Exchange-Traded Fund VIII | 13G/A | 20.95% | Oct 31, 2026 | 8d |
| Orbis Investment Management Limited | RXO RXO, Inc. | 13G/A | 13.8% | Oct 31, 2026 | 8d |
| T. Rowe Price Investment Management, Inc. | MSGK MSG Knickerbockers Corp. | 13G/A | 14.1% | Oct 31, 2026 | 8d |
| SONA ASSET MANAGEMENT (US) LLC | BACC Blue Acquisition Corp | 13G/A | 0% | Oct 31, 2026 | 8d |
| First Trust Portfolios L.P. | CAAA First Trust Exchange-Traded Fund IV | 13G | 67.1% | Oct 31, 2026 | 8d |